APC promoter hypermethylation was not correlated with clinical stage and tumor grade, but was associated with histological subtype in which it was significantly lower in serous carcinoma than in non-serous carcinoma, indicating that APC promoter hypermethylation was correlated with a decreased risk of serous carcinoma. This evidence concerns the gene APC and serous adenocarcinoma.